Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRx-139 vs placebo in severe adult periodontitis
2005-001440-23Phase 2Terminated
- Sponsor
- CombinatoRx
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in periodontitis comparing CRx-139 arm with Placebo arm (2 arms). Primary endpoints: Pocket depth reduction over six weeks and Changes in inflammatory cytokines. Started May 2005; status: terminated.
02
Drugs
paroxetine + prednisolone
03
Conditions
periodontitis
Beyond the preview
Go deeper on 2005-001440-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001440-23.